FoRx raises $50 million series A with EQT Life Sciences, Pfizer Ventures, Novartis Venture Fund and M Ventures
08 December 2025
08 December 2025
Total investments received (USD): 60.87M
Round value (USD): 50M
Company: FoRx
Related deals
Tenpoint Therapeutics raises $85M series B with Janus Henderson Investors, Hillhouse Investment, EQT and British Business Bank
Investments
30 January 2026
Exciva secured a €51 million Series B led by Gimv and EQT Life Sciences, joined by LifeArc Ventures, Fountain Healthcare, CARMA FUND, Andera and LBBW..
Investments
04 January 2026
Orbem closed a €55.5 million Series B led by Innovation Industries, joined by Supernova, General Catalyst, 83North, The Venture Collective, Possible Ventures
Investments
03 January 2026
Biorce raised $52 million Series A led by DST Global, joined by Norrsken VC and YZR Capital.
Investments
02 January 2026
Beacon Tx raised $75m in Series C led by Goldman Sachs Alternatives, joined by the RD Fund, Syncona, Forbion, Oxford Science Enterprises, and Advent.
Investments
29 December 2025
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Italy